FIELD: pharmaceuticals.
SUBSTANCE: invention relates to compounds of formula [I'] or pharmaceutically acceptable salts thereof, wherein each of R2, R3 and R4 independently denotes a hydrogen atom, a fluorine atom or methyl; W denotes a single bond, C1-3alkanediyl or -O-CH2CH2-; ring A is as specified in the claim; ring B denotes any of structures of formula [IV]. Invention also relates to a pharmaceutical composition and an agent for preventing/relieving polycystic kidneys containing compounds of formula [I'].
[IV]
EFFECT: technical result is providing a compound of formula [I'], having inhibitory action on enzymes which produce 20-HETE.
15 cl, 85 tbl, 125 ex
Title | Year | Author | Number |
---|---|---|---|
PARTLY SATURATED NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | 2013 |
|
RU2641291C2 |
NEW HYDROXAMIC ACID DERIVATIVE | 2011 |
|
RU2575129C2 |
BICYCLIC HETEROAROMATIC RING DERIVATIVE | 2019 |
|
RU2798838C2 |
4-ISOPROPYLPHENYLGLUCITE DERIVATIVES AS SGLT1 INHIBITORS | 2010 |
|
RU2518896C2 |
DISPIROPYRROLIDINE DERIVATIVES | 2012 |
|
RU2612534C2 |
C-4" POSITION SUBSTITUTED MACROLIDE DERIVATIVE | 2012 |
|
RU2599718C2 |
PHENYLPYRAZOL DERIVATIVES | 2008 |
|
RU2480456C2 |
BICYCLIC COMPOUND AND USE THEREOF FOR SUV39H2 INHIBITION | 2016 |
|
RU2729187C1 |
C-PHENYL GLYCITOL COMPOUND FOR TREATING DIABETES | 2007 |
|
RU2437876C2 |
NEW NICOTINAMIDE DERIVATIVE OR SALT THEREOF | 2011 |
|
RU2560163C2 |
Authors
Dates
2020-08-24—Published
2017-02-14—Filed